January 21, 2026
RA Jainee
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund
| Fund at a Glance | |
| NAV Growth (Rs.) | 41.85 |
| NAV Bonus (Rs.) | — |
| NAV IDCW (Rs.) | 25.27 |
| Min. Investment (Rs.) | 5,000 |
| Min. SIP Investment (Rs.) | 100 |
| Min. No of Cheques | 6 |
| Benchmark | BSE Healthcare TRI |
| AUM Rs. | 6,456 Cr |
| (As on 31-Dec-2025) | |
| Expense | 1.02% |
| 1 Year Return (%) | 2.65 |
| 3 Year Return (%) | 27.41 |
| 5 Year Return (%) | 17.51 |
| 10 Year Return (%) | — |
| Return Since Launch | 20.98% |
⚖️ Sahifund Review – ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ✔
PLUS: Stability, track record, cost efficiency
X
MINUS: Large AUM, large-cap bias, momentum lag
X
Sahifund View (Decisive Line):
X
👉 Apply Online | Ask Us MF Queries |
| NFO Guidance |
What lies ahead? Below we decode returns consistency, portfolio concentration, peer positioning and risk profile in detail.
Suitable For Which Investors?
Nobody should invest in Pharma funds in our opinion, because:
• They have a narrow focus on only pharmaceutical and healthcare companies
• Instead, diversified equity funds which invest across sectors are better
If you still choose to invest:
1. Invest only through SIP
2. Have a 7+ year investment horizon
3. Be prepared to withstand interim sharp declines in investment value
Fund’s Investment Strategy:
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Fund Manager:
1) Dharmesh Kakkad
Education: Mr. kakkad is B.com., CA & CFA.
Experience: He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Investment Details
| Min. Investment (Rs) | 5,000 |
| Min. Addl Investment (Rs) | 1,000 |
| Min. SIP Investment (Rs) | 100 |
| Min. Withdrawal (Rs) | 1 |
| Min. No of Cheques | 6 |
| Min. Balance (Rs) | — |
| Lock-in Period | NA |
| Exit Load | 1% for redemption within 15 days |
Basic Details of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund
| Fund House | ICICI Prudential Mutual Fund |
| Launch Date | 13-Jul-18 |
| Return Since Launch | 20.98% |
| Benchmark | BSE Healthcare TRI |
| Riskometer | Very High |
| Type | Open-ended |
| Assets (RS) | 6,456 Cr |
| (As on 31-Dec-2025) | |
| Expense | 1.02% |
| (As on 31-Dec-2025) | |
| Risk Grade | Average |
| Return Grade | High |
| Turnover | 60.00% |
Trailing Returns (%)
| Fund name | YTD | 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | 7Y | 10Y |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | -2.79 | -1.09 | -2.61 | -3.88 | -4.39 | 2.65 | 27.41 | 17.51 | 22.48 | — |
| BSE Healthcare TRI | -2.16 | -1.16 | -2.00 | -4.06 | -5.17 | 1.24 | 23.75 | 14.92 | 17.83 | — |
| Equity: Sectoral-Pharma | -1.62 | -1.02 | -1.33 | -2.96 | -3.76 | 1.84 | 22.53 | 15.35 | 20.98 | — |
| Rank within category | 24 | 17 | 24 | 16 | 15 | 7 | 1 | 1 | 2 | — |
| Number of funds in category | 24 | 24 | 24 | 23 | 23 | 21 | 12 | 10 | 7 | 4 |
Peer Comparison of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund
| Rating | 1 Year Returns | 3 Year Returns | 5 Year Returns | Expense Ratio (%) | Net Assets (Rs. Cr) | Return Since Launch (%) | Exit Load (Days) | Fund Age | Turnover (%) | |
| ICICI Pru Pharma Healthcare and Diagnostics Dir | 5 star | 2.65 | 27.41 | 17.51 | 1.02 | 6,456 | 20.98 | 1.00 (15) | 7Y 6M | 60.00 |
| SBI Healthcare Opportunities Dir | 4 star | 1.02 | 24.44 | 16.72 | 0.91 | 3,989 | 17.23 | 0.50 (15) | 13Y | 11.00 |
| DSP Healthcare Dir | 4 star | -3.68 | 22.04 | 16.06 | 0.61 | 3,114 | 22.60 | 0.50 (30) | 7Y 1M | 8.00 |
| UTI Healthcare Dir | 4 star | 0.60 | 24.42 | 15.18 | 1.28 | 1,102 | 15.55 | 1.00 (30) | 13Y | 31.00 |
| Nippon India Pharma Dir | 3 star | 1.60 | 22.20 | 15.21 | 0.92 | 8,265 | 17.30 | 1.00 (30) | 13Y | 17.00 |
Portfolio Analysis of ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund
| No. of Stocks | 39 |
| Top 10 Stocks | 61.94% |
| Top 5 Stocks | 41.31% |
| Top 3 Sectors | 97.87% |
| Portfolio P/B Ratio | 4.26 |
| Portfolio P/E Ratio | 31.33 |
Portfolio Breakup
| Fund | Category | |
| Average Mkt Cap (Rs Cr) | 48,911 | 78,928 |
| Giant (%) | — | — |
| Large (%) | 35.63 | 43.92 |
| Mid (%) | 26.39 | 30.52 |
| Small (%) | 37.98 | 28.49 |
| Tiny (%) | — | — |
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully
Quicklinks
- Chanakyanipothi.com
- Staffavailable.com
- BigGaddi.com
- Latest IPO GMP
- Best Stocks to buy today
- Grey Market Premium
- Upcoming IPOs
- Subscription Status